GeneFerm Biotechnology Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	663.87	677.1	521.16	793.77	633.96	522.33
Revenue Growth (YoY)	16.63%	29.92%	-34.34%	25.21%	21.37%	41.82%
Cost of Revenue	487.2	486.3	424.42	507.42	411.8	329.68
Gross Profit	176.67	190.8	96.75	286.35	222.16	192.65
Selling, General & Admin	111.72	111.22	102.93	104.88	96.71	88.82
Research & Development	33.49	33.54	29.31	28.33	24.18	23.56
Operating Expenses	145.2	144.72	131.15	132.79	120.17	113.82
Operating Income	31.47	46.08	-34.41	153.57	101.99	78.84
Interest Expense	-6.27	-6.22	-4.44	-4.17	-3.82	-7.32
Interest & Investment Income	2.16	1.82	1.54	0.92	0.33	0.21
Currency Exchange Gain (Loss)	-9.11	-9.11	4.8	0.84	9.66	-2.67
Other Non Operating Income (Expenses)	2.36	2.42	5.03	2.27	2.6	1.51
EBT Excluding Unusual Items	20.61	34.98	-27.49	153.42	110.76	70.57
Gain (Loss) on Sale of Investments	-	-	-	-	-0.43	-
Gain (Loss) on Sale of Assets	-0.28	-0.28	0.02	0.01	-0.11	0.04
Other Unusual Items	-	-	-	-	-	-0.21
Pretax Income	20.33	34.7	-27.47	153.43	110.21	70.4
Income Tax Expense	4.63	5.83	-4.94	28.81	16.76	12.98
Net Income	15.7	28.86	-22.53	124.62	93.45	57.41
Net Income to Common	15.7	28.86	-22.53	124.62	93.45	57.41
Net Income Growth	-	-	-	33.35%	62.78%	1167.67%
Shares Outstanding (Basic)	41	41	41	41	41	40
Shares Outstanding (Diluted)	41	42	41	42	43	46
Shares Change (YoY)	-	0.11%	-0.36%	-2.26%	-8.00%	65.83%
EPS (Basic)	0.38	0.70	-0.54	3.01	2.26	1.45
EPS (Diluted)	0.38	0.70	-0.54	2.99	2.20	1.32
EPS Growth	-	-	-	35.63%	66.87%	725.71%
Free Cash Flow	61.09	75.89	-14.31	120.37	-155.74	-32.65
Free Cash Flow Per Share	1.47	1.83	-0.34	2.89	-3.66	-0.70
Dividend Per Share	0.700	0.700	-	2.000	1.500	1.000
Dividend Growth	-	-	-	33.33%	50.00%	1103.93%
Gross Margin	26.61%	28.18%	18.56%	36.08%	35.04%	36.88%
Operating Margin	4.74%	6.80%	-6.60%	19.35%	16.09%	15.09%
Profit Margin	2.37%	4.26%	-4.32%	15.70%	14.74%	10.99%
Free Cash Flow Margin	9.20%	11.21%	-2.74%	15.17%	-24.57%	-6.25%
EBITDA	97.93	113.48	37.89	219.41	145.16	117.76
EBITDA Margin	14.75%	16.76%	7.27%	27.64%	22.90%	22.55%
D&A For EBITDA	66.46	67.41	72.3	65.84	43.16	38.92
EBIT	31.47	46.08	-34.41	153.57	101.99	78.84
EBIT Margin	4.74%	6.80%	-6.60%	19.35%	16.09%	15.09%
Effective Tax Rate	22.79%	16.81%	-	18.78%	15.21%	18.44%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.